Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating children autism

A technology of autism and medicine, which is applied in the field of medicine for the treatment of children with autism, achieving good safety and clear curative effect

Active Publication Date: 2014-02-05
WUHU LUYE PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

According to WHO reports, the global incidence of autism in children is between 0.02% and 0.2%, and that in my country is between 0.03% and 0.10%. , which adversely affects the national population policy and the future development of society

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for treating children autism
  • Medicament for treating children autism

Examples

Experimental program
Comparison scheme
Effect test

experiment example

[0014] normal information

[0015] 48 cases of children with autism were selected and treated, including 36 males and 12 females; 17 cases aged 1-3 years, 21 cases aged 3-5 years, 10 cases aged 5-9 years, with an average age of 5.51 years; months - 6 years, with an average of 3.78 years.

[0016] Diagnostic criteria

[0017] According to the diagnostic criteria of autism in infants and young children in the "Diagnostic and Statistical Booklet of Mental Disorders". The specific implementation standards are: ① meet the above criteria; ② age under 10 years old; ③ voluntarily accept this test, and can persist in taking medicine and nursing care for 6 months; ④ no concurrent history of schizophrenia, selective mutism, epilepsy; ⑤ The family members agreed to take the medicine and signed the informed consent.

[0018] treatment method

[0019] Use the decoction prepared in Example 1 to treat. 1 time a day, 50 ml orally each time, continuous treatment for 24 weeks.

[0020] Eff...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicament for treating children autism. The medicament is prepared from the following substances in weight ratio: taxillus delavayi, bilobate grewia, lombardy poplar, labiatae leucas, bamboo fungus, spurless columbine, smallflower pellitory root, arrowroot, contorted tanglehead herb, pilea notata, pyrrosia leaf, mushroom, common calanthe herb and parthenocissus himalayana planch. All components of the medicament for treating children autism provided by the invention are natural materials, so that the safety is relatively good, the curative effect is accurate and the medicament is suitable for large scale clinical popularization.

Description

technical field [0001] The invention relates to the field of child care, in particular to a medicament for treating children with autism. Background technique [0002] Medically, autism is called autism, which is a typical pervasive developmental disorder in children. Clinical psychology believes that children with autism often involve language, cognition, social skills and other psychological developmental disorders, usually onset around 3 years old, manifested as social ability impairment, language development impairment, rigid behavior and narrow interests Wait. According to WHO reports, the global incidence of autism in children is between 0.02% and 0.2%, and that in my country is between 0.03% and 0.10%. , which adversely affects the national population policy and the future development of society. Contents of the invention [0003] The object of the present invention is to provide a medicament for treating children's autism. [0004] In order to achieve the purpos...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/899A61P25/00
Inventor 张士香
Owner WUHU LUYE PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com